SILO
Silo Pharma, Inc.
5.95
1 x 4.45
1 x 8.10
bid
ask
-
0.22
3.57%
10:16 AM
timesize
| Ytd | 16.67% | |
| 1y | -36.97% |
5.89
day range
6.28
3.31
52 week range
15.15
| Open | 6.17 | Prev Close | 6.17 | Low | 5.89 | High | 6.28 | Mkt Cap | 6.55M |
| Vol | 20.32K | Avg Vol | 298.91K | EPS | -5.85 | P/E | N/A | Forward P/E | -1.26 |
| Beta | 1.36 | Short Ratio | 0.98 | Inst. Own | 2.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 6.31 | 200-d Avg | 6.63 | 1yr Est | 10.00 |
| Income Statement | |||
| Total Revenue | 18.03K | ||
| Revenues (USD) | 18.03K | ||
| Cost of Revenue | 20.69K | ||
| Gross Profit | -2.66K | ||
| Operating Expenses | 1.59M | ||
| Research and Development Expense | 1.01M | ||
| Selling, General and Administrative Expense | 323.44K | ||
| Operating Income | -1.59M | ||
| Interest Expense | 3.37K | ||
| Net Income | -1.65M | ||
| Net Income Common Stock | -1.65M | ||
| Net Income Common Stock (USD) | -1.65M | ||
| Consolidated Income | -1.65M | ||
| Earnings per Basic Share | -1.80 | ||
| Earnings per Basic Share (USD) | -1.80 | ||
| Earnings per Diluted Share | -1.80 | ||
| Earning Before Interest & Taxes (EBIT) | -1.64M | ||
| Earning Before Interest & Taxes (USD) | -1.64M | ||
| Weighted Average Shares | 913.95K | ||
| Weighted Average Shares Diluted | 913.95K | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.90M | ||
| Cash and Equivalents (USD) | 3.90M | ||
| Investments | 2.37M | ||
| Investments Current | 2.37M | ||
| Current Assets | 6.80M | ||
| Total Assets | 7.02M | ||
| Current Liabilities | 704.85K | ||
| Total Liabilities | 1.34M | ||
| Accumulated Retained Earnings (Deficit) | -21.14M | ||
| Accumulated Other Comprehensive Income | 8.72K | ||
| Shareholders Equity | 5.68M | ||
| Shareholders Equity (USD) | 5.68M | ||
| Assets Non-Current | 214.44K | ||
| Deferred Revenue | 703.55K | ||
| Goodwill and Intangible Assets | 214.44K | ||
| Liabilities Non-Current | 631.45K | ||
| Trade and Non-Trade Payables | 632.74K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.94K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -846.19K | ||
| Net Cash Flow from Investing | -23.56K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -23.56K | ||
| Net Cash Flow from Operations | -822.62K | ||
| Share Based Compensation | 56.62K | ||